cell cycle SPECIFIC agents Flashcards
VINCA ALKALOIDS
- inhibit function of microtubules during M phase (mitosis phase)
- IV use only*
- FATAL IF GIVEN BY OTHER ROUTE***
- peripheral sensory & autonomic neuropathies (constipation) are common
- common side effect b/c microtubules play role in axonal transport in neurons
- *potent VESICANTS**
- use warm compress & hyaluronidase
vinCristine = more CNS toxicity than other vinca alkaloids
vinorelBine & vinBlastine = more Bone marrow suppression over vincristine
vincristine
Vincasar PFS
- vinca alkaloid = inhibit function of microtubules during M phase
- NOT myelosuppressive
- capped at 2mg/dose
- higher doses associated with increased risk of neuropathy
vinblastine
vinelborine
Velban
Navelbine
- vina alkaloids = inhibit function of microtubules during M phase
- myelosuppressive
B think bone marrow = myelosuppressive
vincristine liposomal
Marqibo
-not interchangeable with vincristine-
VINCA ALKALOIDS
Boxed Warnings
Side Effects
::: Boxed Warnings :::
- vesicants
- for IV administration only
- intrathecal administration = death
::: Side Effects :::
- peripheral sensory neuropathy (paresthesias)
- autonomic neuropathy (gastroparesis, constipation)
- SIADH
TAXANES
- inhibit function of microtubules during M phase (mitotic phase)
- peripheral sensory neuropathies common side effects = microtubules are important part of axonal transport in neurons
- SEVERE infusion-related hypersensitivity reactions
- FATAL ANAPHYLAXIS
- metabolized by liver
- dose adjustment for hepatic impairment
- DDI = gives taxanes before platinum-based compounds
- elimination of taxanes is reduced when given after cisplatin/carboplatin
Carbo/Taxol = Taxol runs first
paclitaxel
Taxol
- taxane = inhibit function of microtubules during M phase
HSR = hypersensitivity reaction
- pre meds include diphenhydramine, corticosteroid H2RA
docetaxel
Taxotere
Docefez
- taxane = inhibit function of microtubules during M phase
HSR
- pre medicate with corticosteroids for 3 days, starting 1 day prior to docetaxel
- causes severe fluid retention (pleural effusion, cardiac tamponade and/or edema)
- pre medicate with dexamethasone
- some formulations contain alcohol and may cause symptoms of alcohol intoxication
cabazitaxel
Jevtana
- taxane = inhibit function of microtubules during M phase
HSR
- pre meds include diphenhydramine, corticosteroid H2RA
- least alopecia of all taxanes
paclitaxel albumin-bound
Abraxane
- taxane = inhibit function of microtubules during M phase
- paclitaxel bound to albumin without a solvent system
- only isolated case reports of allergic reaction
- no premedication required
TAXANES
Boxed Warnings
Side Effects
& Notes
::: BOXED WARNINGS :::
- severe HSR except Abraxane
- myelosuppression
- docetaxel = fluid retention
::: SIDE EFFECTS :::
- peripheral sensory neuropathy
- myalgias
- arthalgias
- hepatoxicity
- alopecia (less with cabazitaxel)
::: NOTES :::
- HSR are due to solvent systems
- paclitaxel solvent = Cremophor EL
- docetaxel solvent = polysorbate 80
*PVC-FREE BAG + TUBING
due to leaching of DEHP
-except for Abraxane
Topoisomerase I Inhibitors (S phase)
- block the coiling and uncoiling of double-stranded DNA helix during S-phase
- causes single and double strand breaks in DNA and prevents religation of single strand breaks (sealing DNA strands back together)
BOXED WARNINGS
*myelosuppression
SIDE EFFECTS
- NVD
- alopecia
- diarrhea
- abdominal pain
IRINOTECAN
Camptosar
topoisomerase I inhibitor (S phase)
- give ATROPINE to prevent acute cholinergic symptoms
- acute cholinergic symptoms = flushing, sweating, abdominal cramps, diarrhea
- LOPERAMIDE for DELAYED DIARRHEA (up to 24mg/day)
- homozygous UGT1A1*28 allele are at increased risk for neutropenia and delayed diarrhea
TOPOTECAN
hycamtin
- topoisomerase I inhibitor (S phase)
- ANC must be above >1500
- platelets must be above >100
Topoisomerase II Inhibitors (G2)
- block coiling and uncoiling of double-stranded DNA during G2 phase
- causes single and double strand breaks in DNA and prevents religation of single strand breaks
BOXED WARNING
*myelosuppression
SIDE EFFECTS
- hypersensitivity reactions
- anaphylaxis
- secondary malignancies